ANNA MUSSONE: Open Payments
NPI 1528314812 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 72 payments from 20 companies in 2025. Trend: 2023 $1,333 · 2024 $1,361 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $236 |
| Actelion Pharmaceuticals US, Inc. | 4 | $205 |
| Kestra Medical Technology Services, Inc. | 6 | $196 |
| PFIZER INC. | 8 | $190 |
| CVRx, Inc. | 4 | $150 |
| E.R. Squibb & Sons, L.L.C. | 14 | $137 |
| SCPHARMACEUTICALS INC. | 2 | $135 |
| Novo Nordisk Inc | 1 | $109 |
| AtriCure, Inc. | 3 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
Products named: REPATHA, Assure WCD, ELIQUIS, UPTRAVI, Barostim Neo System, FUROSCIX, CAMZYOS, Ozempic.
Industry payments across FL — which companies pay providers there.
